[HTML][HTML] Immunological characteristics in type 2 diabetes mellitus among COVID-19 patients

M Han, K Ma, X Wang, W Yan, H Wang, J You… - Frontiers in …, 2021 - frontiersin.org
Clinical Trial Registration www. ClinicalTrials. gov, identifier: NCT04365634. Context
Diabetes mellitus was associated with increased severity and mortality of disease in COVID …

Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.

M Han, K Ma, X Wang, W Yan, H Wang… - Frontiers in …, 2021 - europepmc.org
Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients

M Han, K Ma, X Wang, W Yan, H Wang… - Covid-19 and …, 2022 - books.google.com
Objective: We aim to explore the clinical and immunological features of type 2 diabetes
mellitus (T2DM) among COVID-19 patients. Design and Methods: In this retrospective study …

[PDF][PDF] Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients

M Han, K Ma, X Wang, W Yan, H Wang… - Front. Endocrinol. 12 …, 2021 - scienceopen.com
Objective: We aim to explore the clinical and immunological features of type 2 diabetes
mellitus (T2DM) among COVID-19 patients. Design and Methods: In this retrospective study …

[HTML][HTML] Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients

M Han, K Ma, X Wang, W Yan, H Wang… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients

M Han, K Ma, X Wang, W Yan… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Clinical trial registration www. ClinicalTrials. gov, identifier: NCT04365634. Context
Diabetes mellitus was associated with increased severity and mortality of disease in COVID …